Arrowhead Pharmaceuticals Inc (FRA:HDP1)
€ 24.66 4.54 (22.56%) Market Cap: 3.08 Bil Enterprise Value: 2.92 Bil PE Ratio: 0 PB Ratio: 17.54 GF Score: 48/100

Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Mar 18, 2021 / 05:00PM GMT
Release Date Price: €60.42 (+0.73%)
Operator

The line is now open for the 2021 Annual Meeting of Stockholders of Arrowhead Pharmaceuticals.

Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director

Good morning, and thank you for joining our virtual meeting of stockholders. I am Christopher Anzalone, the President, CEO and Director of Arrowhead and will be serving as Chairman for today's meeting. The polls are open for voting. If you have a question, you may submit it via the medium portal.

With us today are Doug Given, Chairman of the Board; Mike Perry, Lead Director and Chair of the Compensation Committee; Will Waddill, Director and Chair of the Audit Committee; Mauro Ferrari, Director; Oye Olukotun, Director; also present are the following members of management; Ken Myszkowski, Chief Financial Officer; Patrick O'Brien, General Counsel and Corporate Secretary; Vince Anzalone, VP of Investor Relations; and representatives of Rose, Snyder & Jacobs, our independent registered public accounting firm. I hereby call this meeting to order. It has been duly called and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot